Literature DB >> 16945762

Adjuvant chemotherapy for resected non-small-cell lung cancer--ANITA takes the stage.

Christopher G Azzoli.   

Abstract

Mesh：

Year:  2006        PMID： 16945762     DOI： 10.1016/S1470-2045(06)70838-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.

Authors:  Sai Yendamuri; Adrienne Groman; Austin Miller; Todd Demmy; Mark Hennon; Elisabeth Dexter; Anthony Picone; Chukwumere Nwogu; Grace K Dy
Journal:  Eur J Cardiothorac Surg       Date:  2018-03-01       Impact factor: 4.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.